Stephen Goutman, MD
Enriched profileAssociate Professor of Neurology; Director, Pranger ALS Clinic · University of Michigan
Stephen Goutman is Associate Professor of Neurology; Director, Pranger ALS Clinic at University of Michigan. OpenAlex indexes 125 publications with 7,594 citations (h-index 37); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 18 Oct 2026
Stephen Goutman, M.D., is Associate Professor of Neurology at University of Michigan. The public record shows 125 publications with 7,594 citations (h-index 37), centered on Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Alzheimer's disease research and treatments. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 1 companies, 8 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · Amyotrophic lateral sclerosis & frontotemporal degeneration
- Top research focus: Amyotrophic Lateral Sclerosis Research
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 45 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 77.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- EIM Via the Myolex mScan as an ALS Biomarker
Sponsor: Beth Israel Deaconess Medical Center
- A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects
Sponsor: University of Michigan
Industry payments
Updated 18 Oct 2026
1 company reported payments to CMS in program years 2023–2024. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20241 payment
- Biogen, Inc.Program year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
76.7%Benzothiazole29.1%Riluzole100%Part D≥43 patientsOther nervous system drugs27.8%Radicava Ors100%Part D≥12 patients+ 5 more classes in this area
Musculoskeletal
17%gamma-Aminobutyric Acid-ergic Agonist17%Baclofen100%Part D≥21 patientsMetabolism & gastrointestinal
6.3%Anticholinergic6.3%Atropine Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
8 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Transcriptomics of blood samples in ALS: An untapped resource to advance diagnosis, prognosis, and drug discovery and to gain insights into molecular subtypes of disease
University of Michigan at Ann Arbor
FY2026$619,212R01NS148128 - Spectral flow cytometry identifies new immune signatures that provide personalized ALS risk and progression biomarkers and therapeutic targets
University of Michigan at Ann Arbor
FY2026$500,000U01TS000351 - Integrating the exposome and epigenome identifies determinants of ALS risk, survival, and pathogenesis
University of Michigan at Ann Arbor
FY2025$3,133,754R01ES037968
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Multidisciplinary clinic attendance and patterns of care in the U.S. National ALS Registry, 2013-2023.
Amyotrophic lateral sclerosis & frontotemporal degeneration
Article2026 - Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis.
Annals of clinical and translational neurology
Article2026 - Air pollution and mortality in a University of Michigan amyotrophic lateral sclerosis cohort: a survival analysis.
Environmental health
Article2026 - Natural Killer Cell Dysregulation During ALS Disease Progression: A Gene Expression Analysis.
Neurology open access
Article2026 - Sex Hormones Associate With Amyotrophic Lateral Sclerosis Risk and Survival.
Annals of clinical and translational neurology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Amyotrophic lateral sclerosisArticle1,127 citations2022
- 02Genome-wide Analyses Identify KIF5A as a Novel ALS GeneArticle671 citations2018
- 03Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisArticle534 citations2020
- 04Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosisArticle461 citations2022
- 05Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosisArticle399 citations2022
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/stephen-goutman-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
als.org/blog/dr-stephen-goutman-passionate-clinician-dedicated-improving-lives-people-als
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →als.org ↗ - Other
neals.org/people-living-with-als/educational-webinars/epigenetics-in-als
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neals.org ↗ - Other
iamals.org/als-calendar/les-turner-als-foundation-april-learning-series-the-exposome
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iamals.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of Chicago Pritzker School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uofmhealth.org ↗ - Master's in Clinical Research Design and Statistical Analysis
University of Michigan
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uofmhealth.org ↗ - Board certified in Neurology
Neuromuscular Medicine, and Electrodiagnostic Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →als.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →als.org ↗
Secondary affiliations
appointments beyond the home institution- Associate Director
ALS Center of Excellence, Michigan Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uofmhealth.org ↗
Media & interviews
press, podcasts and appearancesEvery item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
Eva Feldman, MD
University of Michigan
Matthias Kretzler, MD
University of Michigan
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health